182 related articles for article (PubMed ID: 32940288)
1. Two-photon photodynamic ablation of tumour cells using an RGD peptide-conjugated ruthenium(ii) photosensitiser.
Zhao Z; Qiu K; Liu J; Hao X; Wang J
Chem Commun (Camb); 2020 Oct; 56(83):12542-12545. PubMed ID: 32940288
[TBL] [Abstract][Full Text] [Related]
2. Polymeric Encapsulation of a Ruthenium Polypyridine Complex for Tumor Targeted One- and Two-Photon Photodynamic Therapy.
Karges J; Li J; Zeng L; Chao H; Gasser G
ACS Appl Mater Interfaces; 2020 Dec; 12(49):54433-54444. PubMed ID: 33238711
[TBL] [Abstract][Full Text] [Related]
3. Ruthenium(II) polypyridyl complexes as mitochondria-targeted two-photon photodynamic anticancer agents.
Liu J; Chen Y; Li G; Zhang P; Jin C; Zeng L; Ji L; Chao H
Biomaterials; 2015 Jul; 56():140-53. PubMed ID: 25934287
[TBL] [Abstract][Full Text] [Related]
4. Highly Charged Ruthenium(II) Polypyridyl Complexes as Lysosome-Localized Photosensitizers for Two-Photon Photodynamic Therapy.
Huang H; Yu B; Zhang P; Huang J; Chen Y; Gasser G; Ji L; Chao H
Angew Chem Int Ed Engl; 2015 Nov; 54(47):14049-52. PubMed ID: 26447888
[TBL] [Abstract][Full Text] [Related]
5. Ruthenium(II) complexes as bioorthogonal two-photon photosensitizers for tumour-specific photodynamic therapy against triple-negative breast cancer cells.
Lin M; Zou S; Liao X; Chen Y; Luo D; Ji L; Chao H
Chem Commun (Camb); 2021 May; 57(36):4408-4411. PubMed ID: 33949487
[TBL] [Abstract][Full Text] [Related]
6. A biotinylated ruthenium(ii) photosensitizer for tumor-targeted two-photon photodynamic therapy.
Li J; Zeng L; Xiong K; Rees TW; Jin C; Wu W; Chen Y; Ji L; Chao H
Chem Commun (Camb); 2019 Sep; 55(73):10972-10975. PubMed ID: 31453611
[TBL] [Abstract][Full Text] [Related]
7. Critical Overview of the Use of Ru(II) Polypyridyl Complexes as Photosensitizers in One-Photon and Two-Photon Photodynamic Therapy.
Heinemann F; Karges J; Gasser G
Acc Chem Res; 2017 Nov; 50(11):2727-2736. PubMed ID: 29058879
[TBL] [Abstract][Full Text] [Related]
8. Boosting two-photon photodynamic therapy with mitochondria-targeting ruthenium-glucose conjugates.
Liu J; Liao X; Xiong K; Kuang S; Jin C; Ji L; Chao H
Chem Commun (Camb); 2020 May; 56(43):5839-5842. PubMed ID: 32330213
[TBL] [Abstract][Full Text] [Related]
9. Strained ruthenium complexes are potent light-activated anticancer agents.
Howerton BS; Heidary DK; Glazer EC
J Am Chem Soc; 2012 May; 134(20):8324-7. PubMed ID: 22553960
[TBL] [Abstract][Full Text] [Related]
10. Amphiphilic Gemini Iridium(III) Complex as a Mitochondria-Targeted Theranostic Agent for Tumor Imaging and Photodynamic Therapy.
Yi S; Lu Z; Zhang J; Wang J; Xie Z; Hou L
ACS Appl Mater Interfaces; 2019 May; 11(17):15276-15289. PubMed ID: 30968687
[TBL] [Abstract][Full Text] [Related]
11. Heterometallic Ru-Pt metallacycle for two-photon photodynamic therapy.
Zhou Z; Liu J; Rees TW; Wang H; Li X; Chao H; Stang PJ
Proc Natl Acad Sci U S A; 2018 May; 115(22):5664-5669. PubMed ID: 29760069
[TBL] [Abstract][Full Text] [Related]
12. The stepwise photodamage of organelles by two-photon luminescent ruthenium(ii) photosensitizers.
Qiu K; Wen Y; Ouyang C; Liao X; Liu C; Rees TW; Zhang Q; Ji L; Chao H
Chem Commun (Camb); 2019 Sep; 55(75):11235-11238. PubMed ID: 31469153
[TBL] [Abstract][Full Text] [Related]
13. A mitochondria-targeting dinuclear Ir-Ru complex as a synergistic photoactivated chemotherapy and photodynamic therapy agent against cisplatin-resistant tumour cells.
Zhang C; Guan R; Liao X; Ouyang C; Rees TW; Liu J; Chen Y; Ji L; Chao H
Chem Commun (Camb); 2019 Oct; 55(83):12547-12550. PubMed ID: 31576841
[TBL] [Abstract][Full Text] [Related]
14. Evaluating the mechanisms of action and subcellular localization of ruthenium(II)-based photosensitizers.
Mo J; Mai Le NP; Priefer R
Eur J Med Chem; 2021 Dec; 225():113770. PubMed ID: 34403979
[TBL] [Abstract][Full Text] [Related]
15. A mitochondrion-targeting Mn(ii)-terpyridine complex for two-photon photodynamic therapy.
Yang X; Zhang D; Li J; Ji W; Yang N; Gu S; Wu Q; Jiang Q; Shi P; Li L
Chem Commun (Camb); 2020 Aug; 56(63):9032-9035. PubMed ID: 32643722
[TBL] [Abstract][Full Text] [Related]
16. Receptor selective ruthenium-somatostatin photosensitizer for cancer targeted photodynamic applications.
Wang T; Zabarska N; Wu Y; Lamla M; Fischer S; Monczak K; Ng DY; Rau S; Weil T
Chem Commun (Camb); 2015 Aug; 51(63):12552-5. PubMed ID: 26153573
[TBL] [Abstract][Full Text] [Related]
17. Ruthenium Complexes as Anticancer Agents: A Brief History and Perspectives.
Lee SY; Kim CY; Nam TG
Drug Des Devel Ther; 2020; 14():5375-5392. PubMed ID: 33299303
[TBL] [Abstract][Full Text] [Related]
18. Two-photon excited peptide nanodrugs for precise photodynamic therapy.
Cao H; Qi Y; Gao X; Wei ZJ; Xia J; Wang L; Wang H; Yang Y; Li J
Chem Commun (Camb); 2021 Mar; 57(18):2245-2248. PubMed ID: 33554229
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of action of Ru(ii) polypyridyl complexes in living cells upon light irradiation.
Jakubaszek M; Goud B; Ferrari S; Gasser G
Chem Commun (Camb); 2018 Nov; 54(93):13040-13059. PubMed ID: 30398487
[TBL] [Abstract][Full Text] [Related]
20. Ruthenium(II) polypyridyl complexes as emerging photosensitisers for antibacterial photodynamic therapy.
Ng XY; Fong KW; Kiew LV; Chung PY; Liew YK; Delsuc N; Zulkefeli M; Low ML
J Inorg Biochem; 2024 Jan; 250():112425. PubMed ID: 37977020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
